Vinva Investment Management Ltd Takes Position in Teladoc Health, Inc. (NYSE:TDOC)

Vinva Investment Management Ltd bought a new stake in shares of Teladoc Health, Inc. (NYSE:TDOC) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 39,965 shares of the health services provider’s stock, valued at approximately $363,000.

Several other large investors have also recently made changes to their positions in the business. Whipplewood Advisors LLC purchased a new position in Teladoc Health in the 4th quarter worth approximately $29,000. Versant Capital Management Inc raised its stake in Teladoc Health by 313.8% during the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after buying an additional 2,441 shares during the last quarter. Lindbrook Capital LLC raised its stake in Teladoc Health by 78.9% during the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after buying an additional 1,612 shares during the last quarter. PNC Financial Services Group Inc. raised its stake in Teladoc Health by 22.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider’s stock valued at $73,000 after buying an additional 1,439 shares during the last quarter. Finally, KBC Group NV raised its stake in Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after buying an additional 3,714 shares during the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Trading Up 3.1 %

Shares of Teladoc Health stock opened at $8.43 on Friday. The company has a market capitalization of $1.46 billion, a P/E ratio of -1.46 and a beta of 1.27. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The company has a fifty day moving average of $10.42 and a 200 day moving average of $9.73. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.43.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. On average, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. The Goldman Sachs Group decreased their target price on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research note on Monday, March 3rd. Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a research note on Friday, January 24th. Royal Bank of Canada boosted their target price on shares of Teladoc Health from $11.00 to $12.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Needham & Company LLC reiterated a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Finally, Piper Sandler cut their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Eleven research analysts have rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $11.26.

Insider Buying and Selling at Teladoc Health

In other news, insider Adam C. Vandervoort sold 11,011 shares of the company’s stock in a transaction dated Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the sale, the insider now directly owns 64,308 shares in the company, valued at approximately $541,473.36. This represents a 14.62 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.95% of the company’s stock.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.